Skip to main content

Table 3 Brand or licensed brand median unit prices (US$) and medicine price ratios for branded generics and generics considering the brand or licensed brand as reference price, for antibiotics, antidiabetics and antihypertensives, in Brazil, 2002, 2006 and 2010

From: The Brazilian private pharmaceutical market after the first ten years of the generics law

Selected medicines

2002

2006

2010

Originator

Branded generics

Generics

Originator

Branded generics

Generics

Originator

Branded generics

Generics

Antibiotics

 Penicillins

  Amoxicillin a, c

1.02

72.0%

24.9%

1.48

54.9%

38.6%

1.53

46.9%

44.8%

  Amoxicillin+Clavulanic acid a, c

2.03

83.9%

66.8%

3.61

78.5%

49.1%

3.82

64.2%

75.4%

  Ampicillin a, d

1.06

75.2%

50.8%

1.49

49.4%

49.5%

1.82

35.6%

42.7%

 Fluoroquinolones

  Ciprofloxacin a, c

2.71

72.2%

100.3%

10.75

19.1%

31.2%

12.33

15.0%

19.6%

  Levofloxacin a, d

6.01

*

*

9.26

45.1%

54.4%

11.63

39.4%

43.1%

  Norfloxacin a, d

1.50

55.8%

59.4%

1.94

55.9%

60.0%

2.34

53.0%

57.3%

 Cephalosporins

  Cefaclor a, d

1.93

148.8%

*

2.39

144.8%

107.6%

3.57

*

72.2%

  Cefadoxil a, c

3.49

34.8%

43.6%

4.92

29.8%

36.9%

3.07

32.5%

67.1%

  Cefalexin a, d

1.53

78.2%

43.3%

1.74

81.7%

62.7%

2.13

64.0%

54.9%

  Cefuroxime axetil b, c

4.08

*

46.0%

4.99

*

42.5%

6.01

*

61.4%

  Cefalotin b, d

2.79

106.7%

114.3%

3.67

94.0%

80.7%

4.62

101.3%

65.7%

  Cefazolin b, d

5.58

110.4%

*

6.38

60.6%

*

4.29

262.2%

93.3%

  Cefepime b, c

19.10

*

*

25.05

171.3%

71.2%

57.79

87.8%

69.2%

  Ceftazidime b, c

29.97

56.6%

*

31.63

38.9%

47.2%

49.94

30.0%

30.0%

  Ceftriazone b, c

30.73

49.5%

25.4%

45.94

44.2%

23.5%

52.85

30.3%

30.0%

 Macrolides

  Azitromycin a, d

6.91

68.4%

99.3%

6.38

80.6%

116.8%

7.62

48.5%

83.1%

  Claritromycin a, d

3.12

116.1%

82.1%

3.43

88.6%

118.2%

4.11

64.0%

119.3%

  Clindamycin a, c

2.00

97.6%

60.8%

2.84

58.6%

53.9%

3.41

53.0%

52.8%

  Erythromycin a, d

0.64

141.5%

*

0.71

139.8%

*

0.81

85.8%

111.7%

Antidiabetics a, c

 Glibenclamide

0.16

57.9%

66.9%

0.20

63.9%

63.7%

0.25

53.7%

63.5%

 Glimepiride

0.38

161.7%

*

0.53

118.1%

117.0%

0.99

74.2%

78.8%

Antihypertensives a

 Methyldopa c

0.37

167.3%

102.1%

0.48

123.7%

78.4%

0.59

108.5%

72.3%

 Diuretics

  Spironolacton c

0.41

*

*

0.52

73.7%

64.4%

0.57

71.9%

65.7%

  Furosemide c

0.15

106.8%

86.0%

0.11

218.5%

183.6%

0.12

174.6%

139.4%

  Chlorthalidone c

0.19

88.3%

*

0.25

71.4%

66.0%

0.27

65.5%

79.7%

  Amiloride+hydrochlorothiazide c

0.20

97.1%

*

0.26

92.1%

68.1%

0.30

94.7%

64.7%

 Betablockers

  Atenolol c

0.44

68.9%

59.0%

0.61

53.3%

46.8%

0.70

46.9%

41.5%

  Carvedilol c

1.06

65.3%

*

1.57

38.1%

48.8%

1.91

32.7%

46.8%

  Metoprolol c

0.51

*

45.1%

0.36

*

89.2%

0.42

*

87.6%

  Propranolol c

0.11

63.0%

*

0.16

58.7%

56.8%

0.18

60.3%

57.1%

  Sotalol c

0.85

*

79.5%

1.33

65.4%

71.4%

1.58

75.8%

71.0%

  Atenolol+Chlorthalidone c

0.60

71.0%

*

0.83

58.7%

52.2%

0.94

55.3%

49.5%

 Calcium antagonists

  Amlodipine c

1.51

52.7%

50.5%

1.88

36.9%

41.6%

2.11

34.4%

46.2%

  Diltiazem d

0.45

119.6%

29.1%

0.55

140.2%

36.0%

1.01

101.1%

34.7%

  Felodipine c

1.20

*

*

1.62

76.5%

84.1%

1.92

*

50.1%

  Verapamil c

0.40

70.1%

91.4%

0.57

58.2%

52.1%

0.62

42.0%

56.8%

 ACE inhibitors

  Captopril c

0.58

54.0%

57.9%

0.87

38.5%

44.7%

1.09

30.6%

41.1%

  Enalapril c

0.97

39.4%

41.9%

0.46

97.9%

113.8%

0.33

146.2%

170.5%

  Lisinopril c

0.82

59.0%

61.6%

1.09

59.3%

62.3%

1.50

45.5%

53.7%

  Ramipril c

0.66

122.6%

*

2.66

40.7%

42.5%

3.23

30.9%

32.7%

  Captopril+ hydrochlorothiazide c

1.12

68.2%

*

1.57

73.1%

58.6%

1.79

46.4%

60.4%

  Enalapril+ hydrochlorothiazide c

1.04

65.3%

*

1.36

54.5%

61.0%

0.93

87.8%

107.7%

  Lisinopril+ hydrochlorothiazide c

1.10

131.4%

*

1.40

60.9%

108.2%

1.60

69.0%

*

  Ramirpil+ hydrochlorothiazide c

2.18

48.1%

*

3.08

46.6%

*

3.49

37.4%

44.8%

  Losartan d

1.76

62.9%

*

2.48

40.2%

36.4%

1.06

68.4%

63.5%

  Losartan+ hydrochlorothiazide d

1.76

75.2%

*

2.49

35.6%

55.1%

1.54

61.8%

82.1%

  1. The time points are the first quarter of the respective year
  2. *no unit price for generic or branded generic available
  3. aOral presentations
  4. bInjectable preparations
  5. cOriginal brand
  6. dLicensed brand
  7. Medicine price ratios for branded generics and generics considering the brand or licensed brand as reference price with percentages higher than 100% were highlighted in boldface